Using a transgenic mouse model of skin cancer, Coussens et al. showed that transplantation of MMP9-expressing hematopoietic cells can reverse the impaired development of metastatic cancer in MMP9 null mice [89]. The gene discussed is MMP9; the disease is skin cancer.